Boeing delivered 53 commercial aircraft in October, bringing its 2025 year‑to‑date total to 493 jets. The deliveries included 39 737 MAXs and 13 wide‑body aircraft—seven 787 Dreamliners, two 777 freighters, and four 767s—showing a balanced mix across the company’s product lines.
The company reported 15 new orders in October, but after accounting for cancellations the net new order count was eight. The gross figure was highlighted in the original release, but the net number better reflects the company’s demand environment and avoids overstating growth.
The October delivery run was supported by the Federal Aviation Administration’s approval to raise 737 MAX production from 38 to 42 aircraft per month. The approval signals that Boeing’s quality and safety controls have met regulatory standards, enabling the company to scale production without compromising safety or reliability.
Demand for the 787 Dreamliner remains strong, with 320 orders year‑to‑date, while the 777X program continues to face delays, pushing the first delivery to 2027 and adding a $4.9 billion pre‑tax charge to the company’s earnings. These dynamics illustrate the mix of growth opportunities and headwinds in Boeing’s commercial portfolio.
Boeing’s 493 deliveries in the first ten months of 2025 still lag behind Airbus’s 585, underscoring the competitive pressure in the commercial aircraft market. Nevertheless, the company’s backlog of $636 billion—up from $619 billion in Q2—remains a robust indicator of future revenue streams.
CEO Kelly Ortberg emphasized that the company is “making steady progress to stabilize our business” and that the FAA approval for increased 737 MAX output is a key milestone in the recovery plan. He also noted the 777X delay but reiterated focus on development programs and operational stability, signaling confidence in long‑term growth while acknowledging current challenges.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.